Legend Biotech (LEGN) Cash from Operations (2019 - 2025)
Legend Biotech (LEGN) posted Cash from Operations of 12200000.0 for Q4 2025, down 142.36% quarter-over-quarter from 28801000.0 in Q3 2025, and up 85.14% year-on-year from 6589605.26 in Q4 2024.
Legend Biotech (LEGN) Cash from Operations (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has reported Cash from Operations for 7 consecutive years, with 12200000.0 the latest figure, recorded in Q4 2025.
- Cash from Operations for Q4 2025 came in at 12200000.0, up 85.14% year-over-year; the trailing twelve-month figure through Dec 2025 was 100195000.0 (up 30.45% YoY), and the FY2025 annual result was 100200000.0, up 30.42% from the prior year.
- Cash from Operations was 12200000.0 for Q4 2025 at Legend Biotech, down from 28801000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 28801000.0 in Q3 2025 and troughed at 198465000.0 in Q4 2021.
- Average Cash from Operations over 5 years is 58313050.0, with a median of 59228500.0 recorded in 2021.
- Year-over-year, Cash from Operations plunged 13084.86% in 2023 and surged 137.99% in 2025.
- Over 5 years, Cash from Operations stood at 198465000.0 in 2021, then surged by 74.94% to 49742000.0 in 2022, then sank by 92.28% to 95645000.0 in 2023, then climbed by 14.16% to 82100000.0 in 2024, then surged by 85.14% to 12200000.0 in 2025.
- Per Business Quant data, the three most recent Cash from Operations figures were 12200000.0 in Q4 2025, 28801000.0 in Q3 2025, and 13042000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 3.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -2.49 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 201.34 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 1.43 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | - |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 70.50 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -354.17 Mn |
| 10 | Legend Biotech | 11.04 Bn | 10.14 Bn | 242.10 Mn | -12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.20 Mn |
| Dec 31, 2025 | -12.20 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Jun 30, 2025 | -13.04 Mn |
| Jun 30, 2025 | -13.04 Mn |
| Mar 31, 2025 | -103.75 Mn |
| Mar 31, 2025 | -103.75 Mn |
| Dec 31, 2024 | -82.10 Mn |
| Dec 31, 2024 | -82.10 Mn |
| Sep 30, 2024 | -75.82 Mn |
| Sep 30, 2024 | -75.82 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Sep 30, 2023 | -60.85 Mn |
| Sep 30, 2023 | -60.85 Mn |